Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 7
Submit an article Journal homepage
1,485
Views
15
CrossRef citations to date
0
Altmetric
Brief Report

Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy

M. XipellNephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
,
I. VictoriaOncology Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
,
V. HoffmannNephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
,
J. VillarrealNephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
,
A. García-HerreraPathology Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
,
O. ReigOncology Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
,
L. RodasNephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
,
M. BlascoNephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, SpainORCID Iconhttp://orcid.org/0000-0003-0789-7992
ORCID Icon,
E. PochNephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
,
B. MelladoOncology Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, SpainCorrespondence[email protected]
&
L. F. QuintanaNephrology and Renal Transplantation Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, SpainCorrespondence[email protected]
 show all
Article: e1445952 | Received 24 Jan 2018, Accepted 23 Feb 2018, Published online: 26 Mar 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.